Table of Contents Author Guidelines Submit a Manuscript
Sarcoma
Volume 2006, Article ID 83548, 8 pages
http://dx.doi.org/10.1155/SRCM/2006/83548
Clinical Study

Improving Outcomes After Relapse in Ewing's Sarcoma: Analysis of 114 Patients From a Single Institution

Department of Oncology, University College Hospital, 250 Euston Road, London NW1 2PG, UK

Received 16 August 2005; Revised 13 August 2006; Accepted 22 August 2006

Copyright © 2006 Anne M. McTiernan et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C Rodriguez-Galindo, C A Billups, L E Kun et al., “Survival after recurrence of Ewing tumors: the St. Jude children's research hospital experience, 1979–1999,” Cancer, vol. 94, no. 2, pp. 561–569, 2002. View at Publisher · View at Google Scholar
  2. A G Shankar, S Ashley, A W Craft, and C R Pinkerton, “Outcome after relapse in an unselected cohort of children and adolescents with Ewing sarcoma,” Medical and Pediatric Oncology, vol. 40, no. 3, pp. 141–147, 2003. View at Publisher · View at Google Scholar
  3. G Bacci, S Ferrari, A Longhi et al., “Therapy and survival after recurrence of Ewing's tumors: the Rizzoli experience in 195 patients treated with adjuvant and neoadjuvant chemotherapy from 1979 to 1997,” Annals of Oncology, vol. 14, no. 11, pp. 1654–1659, 2003. View at Publisher · View at Google Scholar
  4. A Craft, S Cotterill, A Malcolm et al., “Ifosfamide-containing chemotherapy in Ewing's sarcoma: the second United Kingdom Children's Cancer Study Group and the Medical Research Council Ewing's Tumor Study,” Journal of Clinical Oncology, vol. 16, no. 11, pp. 3628–3633, 1998. View at Google Scholar
  5. M Paulussen, A Craft, and I Lewis, “Ewing tumor of bone—updated report of the European Intergroup Cooperative Ewing's Sarcoma Study EICESS 92,” Proceedings of the American Society of Clinical Oncology, vol. 21, no. abstract, p. 1568, 2002. View at Google Scholar
  6. S J Strauss, A McTiernan, D Driver et al., “Single center experience of a new intensive induction therapy for Ewing's family of tumors: feasibility, toxicity, and stem cell mobilization properties,” Journal of Clinical Oncology, vol. 21, no. 15, pp. 2974–2981, 2003. View at Publisher · View at Google Scholar
  7. E L Kaplan and P Meier, “Nonparametric estimation from incomplete observations,” Journal of the American Statistical Association, vol. 53, no. 282, pp. 457–481, 1958. View at Publisher · View at Google Scholar
  8. D R Cox and D Oakes, Analysis of Survival Data, Chapman and Hall, London, UK, 1984.
  9. J S Whelan, A McTiernan, E Kakouri, and A Kilby, “Carboplatin-based chemotherapy for refractory and recurrent Ewing's tumours,” Pediatric Blood and Cancer, vol. 43, no. 3, pp. 237–242, 2004. View at Publisher · View at Google Scholar
  10. B M Seddon, A McTiernan, M Michelagnoli, S Gabbie, S Daw, and J S Whelan, “High-dose ifosfamide in relapsed or progressive Ewing's sarcoma,” Sarcoma, vol. 9, no. abstract, p. 108, 2005. View at Google Scholar
  11. G Bacci, S Ferrari, F Bertoni et al., “Prognostic factors in nonmetastatic Ewing's sarcoma of bone treated with adjuvant chemotherapy: analysis of 359 patients at the Istituto Ortopedico Rizzoli,” Journal of Clinical Oncology, vol. 18, no. 1, pp. 4–11, 2000. View at Google Scholar
  12. A W Craft, S J Cotterill, J A Bullimore, and D Pearson, “Long-term results from the first UKCCSG Ewing's tumour study (ET-1). United Kingdom Children's Cancer Study Group (UKCCSG) and the Medical Research Council Bone Sarcoma Working Party,” European Journal of Cancer, vol. 33, no. 7, pp. 1061–1069, 1997. View at Publisher · View at Google Scholar
  13. M Paulussen, S Ahrens, J Dunst et al., “Localized Ewing tumor of bone: final results of the Cooperative Ewing's Sarcoma Study CESS 86,” Journal of Clinical Oncology, vol. 19, no. 6, pp. 1818–1829, 2001. View at Google Scholar
  14. L H Wexler, T F DeLaney, M Tsokos et al., “Ifosfamide and etoposide plus vincristine, doxorubicin, and cyclophosphamide for newly diagnosed Ewing's sarcoma family of tumors,” Cancer, vol. 78, no. 4, pp. 901–911, 1996. View at Publisher · View at Google Scholar
  15. A G Shankar, C R Pinkerton, A Atra et al., “Local therapy and other factors influencing site of relapse in patients with localised Ewing's sarcoma. United Kingdom Children's Cancer Study Group (UKCCSG),” European Journal of Cancer, vol. 35, no. 12, pp. 1698–1704, 1999. View at Publisher · View at Google Scholar
  16. G Bacci, S Ferrari, M Mercuri et al., “Multimodal therapy for the treatment of nonmetastatic Ewing sarcoma of pelvis,” Journal of Pediatric Hematology/Oncology, vol. 25, no. 2, pp. 118–124, 2003. View at Publisher · View at Google Scholar
  17. F A Hayes, E I Thompson, M Kumar, and H O Hustu, “Long-term survival in patients with Ewing's sarcoma relapsing after completing therapy,” Medical and Pediatric Oncology, vol. 15, no. 5, pp. 254–256, 1987. View at Publisher · View at Google Scholar
  18. M Paulussen, S Ahrens, G Braun-Munzinger et al., “Survival in primary disseminated or relapsed Ewing's tumor-EICESS/CESS data,” Medical and Pediatric Oncology, vol. 27, no. abstract, p. 237, 1996. View at Google Scholar
  19. L M Barker, T W Pendergrass, J E Sanders, and D S Hawkins, “Survival after recurrence of Ewing's sarcoma family of tumors,” Journal of Clinical Oncology, vol. 23, no. 19, pp. 4354–4362, 2005. View at Publisher · View at Google Scholar
  20. G Bacci, P Picci, S Ferrari et al., “Neoadjuvant chemotherapy for Ewing's sarcoma of bone: no benefit observed after adding ifosfamide and etoposide to vincristine, actinomycin, cyclophosphamide, and doxorubicin in the maintenance phase—results of two sequential studies,” Cancer, vol. 82, no. 6, pp. 1174–1183, 1998. View at Publisher · View at Google Scholar
  21. G Bacci, M Mercuri, A Longhi et al., “Neoadjuvant chemotherapy for Ewing's tumour of bone: recent experience at the Rizzoli Orthopaedic Institute,” European Journal of Cancer, vol. 38, no. 17, pp. 2243–2251, 2002. View at Publisher · View at Google Scholar
  22. S J Cotterill, S Ahrens, M Paulussen et al., “Prognostic factors in Ewing's tumor of bone: analysis of 975 patients from the European Intergroup Cooperative Ewing's Sarcoma Study Group,” Journal of Clinical Oncology, vol. 18, no. 17, pp. 3108–3114, 2000. View at Google Scholar
  23. R Ladenstein, C Lasset, R Pinkerton et al., “Impact of megatherapy in children with high-risk Ewing's tumours in complete remission: a report from the EBMT Solid Tumour Registry,” Bone Marrow Transplantation, vol. 15, no. 5, pp. 697–705, 1995. View at Google Scholar
  24. B Frohlich, S Ahrens, S Burdach et al., “High-dosage chemotherapy in primary metastasized and relapsed Ewing's sarcoma. (EI)CESS,” Klinische Pädiatrie, vol. 211, no. 4, pp. 284–290, 1999. View at Google Scholar
  25. J S Whelan, R J Burcombe, J Janinis, A M Baldelli, and A M Cassoni, “A systematic review of the role of pulmonary irradiation in the management of primary bone tumours,” Annals of Oncology, vol. 13, no. 1, pp. 23–30, 2002. View at Publisher · View at Google Scholar